Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
International Journal of Cardiology|January 18, 2008
Metabolic agents in the management of diabetic coronary patients: a new eraGiuseppe Marazzi, Maurizio Volterrani, Giuseppe M C Rosano
Current Pharmaceutical Design|November 11, 2008
The role of amino acids in the modulation of cardiac metabolism during ischemia and heart failureGiuseppe Marazzi, Salvatore Rosanio, Giuseppe Caminiti, et al.
International Journal of Cardiology|July 23, 2013
Current evidence and future perspectives on n-3 PUFAsFrancesco Pelliccia, Giuseppe Marazzi, Cesare Greco, et al.
American Heart Journal|June 20, 2012
A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary interventionFrancesco Pelliccia, Vincenzo Pasceri, Giuseppe Marazzi, et al.
European Journal of Pharmacology|September 6, 2015
Drug-drug interactions between clopidogrel and novel cardiovascular drugsFrancesco Pelliccia, Fabiana Rollini, Giuseppe Marazzi, et al.
International Journal of Cardiology|November 15, 2011
Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: the NINFE (Nebivololo, Irbesartan Nella Funzione Endoteliale) studyCristiana Vitale, Giuseppe Marazzi, Ferdinando Iellamo, et al.
Clinical Cardiology|February 16, 2002
Continuous 12-lead ST-segment monitoring improves identification of low-risk patients with chest pain and a worse in-hospital outcomeFrancesco Pelliccia, Cinzia Cianfrocca, Giuseppe Marazzi, et al.
International Journal of Cardiology|October 11, 2016
New oral anticoagulants and dual antiplatelet therapy: Focus on apixabanFrancesco Pelliccia, Fabiana Rollini, Giuseppe Marazzi, et al.
The American Journal of Cardiology|November 28, 2015
Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart DiseaseGiuseppe Marazzi, Francesco Pelliccia, Giuseppe Campolongo, et al.
European Heart Journal|October 31, 2003
Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placeboAntonello Silvestri, Pasquale Galetta, Elena Cerquetani, et al.
Pageof 7